De novo mutations of \(\textit{ ELANE}\) gene in three Vietnamese patients with severe congenital neutropenia
Authors
DOI: https://doi.org/10.15625/2615-9023/17080Keywords:
De novo, ELANE, severe congenital neutropenia, Vietnamese, whole-exome sequencingReferences
Bellanne-Chantelot C., Clauin S., Leblanc T., Cassinat B., Rodrigues-Lima F., Beaufils S., Vaury C., Barkaoui M., Fenneteau O., Maier-Redelsperger M., Chomienne C., Donadieu J., 2004. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood, 103(11): 4119-4125. https://doi.org/10.1182/blood-2003-10-3518.
Calyseva J., Vihinen M., 2017. PON-SC - program for identifying steric clashes caused by amino acid substitutions. BMC Bioinformatics, 18(1): 531. https://doi.org/10.1186/s12859-017-1947-7.
Dale D.C., Person R.E., Bolyard A.A., Aprikyan A.G., Bos C., Bonilla M.A., Boxer L.A., Kannourakis G., Zeidler C., Welte K., Benson K.F., Horwitz M., 2000. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood, 96(7): 2317-2322. https://doi.org/10.1182/blood.V96.7.2317.h8002317_2317_2322.
Deordieva E., Shvets O., Voronin K., Maschan A., Welte K., Skokowa J., Novichkova G., Shcherbina A., 2021. Nicotinamide (vitamin B3) treatment improves response to G-CSF in severe congenital neutropenia patients. Br J Haematol, 192(4): 788-792. https://doi.org/10.1111/bjh.17313.
Donadieu J., Beaupain B., Fenneteau O., Bellanne-Chantelot C., 2017. Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history. Br J Haematol, 179(4): 557-574. https://doi.org/10.1111/bjh.14887.
Furutani E., Newburger P.E., Shimamura A., 2019. Neutropenia in the age of genetic testing: Advances and challenges. Am J Hematol, 94(3): 384-393. https://doi.org/10.1002/ajh.25374.
Gauthier-Vasserot A., Thauvin-Robinet C., Bruel A.L., Duffourd Y., St-Onge J., Jouan T., Riviere J.B., Heron D., Donadieu J., Bellanne-Chantelot C., Briandet C., Huet F., Kuentz P., Lehalle D., Duplomb-Jego L., Gautier E., Maystadt I., Pinson L., Amram D., El Chehadeh S., Melki J., Julia S., Faivre L., Thevenon J., 2017. Application of whole-exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability. Am J Med Genet A, 173(1): 62-71. https://doi.org/10.1002/ajmg.a.37969.
Germeshausen M., Deerberg S., Peter Y., Reimer C., Kratz C.P., Ballmaier M., 2013. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia. Hum Mutat, 34(6): 905-914. https://doi.org/10.1002/humu.22308.
Grenda D.S., Murakami M., Ghatak J., Xia J., Boxer L.A., Dale D., Dinauer M.C., Link D.C., 2007. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood, 110(13): 4179-4187. https://doi.org/10.1182/blood-2006-11-057299.
Ittiwut R., Sengpanich K., Lauhasurayotin S., Ittiwut C., Shotelersuk V., Sosothikul D., Suphapeetiporn K., 2020. Clinical and molecular characteristics of Thai patients with ELANE-related neutropaenia. J Clin Pathol, 75(2): 99-103. https://doi.org/10.1136/jclinpath-2020-207139.
Kostman R., 1975. Infantile genetic agranulocytosis. A review with presentation of ten new cases. Acta Paediatr Scand, 362-368. https://doi.org/10.1111/j.1651-2227.1975.tb03847.x.
Li H., Durbin R., 2010. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics, 26(5): 589-595. https://doi.org/10.1093/bioinformatics/btp698.
Makaryan V., Zeidler C., Bolyard A.A., Skokowa J., Rodger E., Kelley M.L., Boxer L.A., Bonilla M.A., Newburger P.E., Shimamura A., Zhu B., Rosenberg P.S., Link D.C., Welte K., Dale D.C., 2015. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr Opin Hematol, 22(1): 3-11. https://doi.org/10.1097/MOH.0000000000000105.
McKenna A., Hanna M., Banks E., Sivachenko A., Cibulskis K., Kernytsky A., Garimella K., Altshuler D., Gabriel S., Daly M., DePristo M.A., 2010. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res, 20(9): 1297-1303. https://doi.org/10.1101/gr.107524.110.
McNulty S.N., Evenson M.J., Riley M., Yoest J.M., Corliss M.M., Heusel J.W., Duncavage E.J., Pfeifer J.D., 2021. A Next-Generation Sequencing Test for Severe Congenital Neutropenia: Utility in a Broader Clinicopathologic Spectrum of Disease. J Mol Diagn, 23(2): 200-211. https://doi.org/10.1016/j.jmoldx.2020.10.014.
Nayak R.C., Trump L.R., Aronow B.J., Myers K., Mehta P., Kalfa T., Wellendorf A.M., Valencia C.A., Paddison P.J., Horwitz M.S., Grimes H.L., Lutzko C., Cancelas J.A., 2015. Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells. J Clin Invest, 125(8): 3103-3116. https://doi.org/10.1172/JCI80924.
Nustede R., Klimiankou M., Klimenkova O., Kuznetsova I., Zeidler C., Welte K., Skokowa J., 2016. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia. Br J Haematol, 172(2): 219-227. https://doi.org/10.1111/bjh.13823.
Rydzynska Z., Pawlik B., Krzyzanowski D., Mlynarski W., Madzio J., 2021. Neutrophil Elastase Defects in Congenital Neutropenia. Front Immunol, 12(653932. https://doi.org/10.3389/fimmu.2021.653932.
Scheike J.A., Baldauf C., Spengler J., Albericio F., Pisabarro M.T., Koksch B., 2007. Amide-to-ester substitution in coiled coils: the effect of removing hydrogen bonds on protein structure. Angew Chem Int Ed Engl, 46(41): 7766-7769. https://doi.org/10.1002/anie.200702218.
Zhang J., Barbaro P., Guo Y., Alodaib A., Li J., Gold W., Ades L., Keating B.J., Xu X., Teo J., Hakonarson H., Christodoulou J., 2016. Utility of next-generation sequencing technologies for the efficient genetic resolution of haematological disorders. Clin Genet, 89(2): 163-172. https://doi.org/10.1111/cge.12573.
Downloads
Metrics
Downloads
PDF Downloaded: 83